More Than 80,000 EpiPens Recalled Overseas More Than 80,000 EpiPens Recalled Overseas

The company that markets EpiPens said the recalled devices may fail to inject its potentially life-saving dose of epinephrine into a patient experiencing anaphylactic shock.News Alerts
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news